MMWR Morb Mortal Wkly Rep. 2012 Nov 16;61(45):909-13.
Epilepsy is a neurologic disorder that negatively affects the quality of life for millions of persons in the United States; however, nationally representative U.S. estimates of the prevalence of epilepsy are scant. To determine epilepsy prevalence among adults, assess their access to care, and provide baseline estimates for a Healthy People 2020 objective ("Increase the proportion of persons with epilepsy and uncontrolled seizures who receive appropriate medical care"), CDC analyzed data from the 2010 National Health Interview Survey (NHIS). The results of that analysis indicated that, in 2010, an estimated 1.0% of U.S. adults and 1.9% of those with annual family income levels ≤$34,999 had active epilepsy. In addition, only 52.8% of adults with active epilepsy reported seeing a neurologic specialist in the preceding 12 months. Public health agencies can work with Epilepsy Foundation state affiliates and other health and human service providers to eliminate identified barriers to care for persons with epilepsy.
癫痫是一种神经系统疾病,会对美国数百万人的生活质量产生负面影响;然而,全美范围内针对癫痫患病率的代表性估计数据却很少。为了确定美国成年人的癫痫患病率,评估他们获得医疗服务的机会,并为“提高癫痫患者和未得到控制的癫痫发作患者获得适当医疗服务的比例”这一 2020 年健康人目标提供基线估计值,疾病预防控制中心分析了 2010 年全国健康访谈调查(NHIS)的数据。分析结果表明,2010 年,美国约有 1.0%的成年人和年收入水平≤$34999 的成年人中有 1.9%患有活动性癫痫。此外,仅有 52.8%的患有活动性癫痫的成年人报告在过去 12 个月内看过神经科专家。公共卫生机构可以与癫痫基金会的州级分支机构以及其他卫生和人类服务提供者合作,消除癫痫患者获得医疗服务的已知障碍。